Search by Drug Name or NDC
NDC 00363-7174-14 LEG CRAMPS PM 12; 3; 12; 12; 6; 6; 12; 12; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 Details
LEG CRAMPS PM 12; 3; 12; 12; 6; 6; 12; 12; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
LEG CRAMPS PM is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is CAUSTICUM; CINCHONA OFFICINALIS BARK; COPPER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SULFUR; TOXICODENDRON PUBESCENS LEAF.
Product Information
| NDC | 00363-7174 |
|---|---|
| Product ID | 0363-7174_fea42376-8bbc-55c2-e053-6294a90ae2c5 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | LEG CRAMPS PM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | oyster shell calcium carbonate, crude, causticum, matricaria recutita, cinchona officinalis bark, copper, lycopodium clavatum spore, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, silicon dioxide, and sulfur |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 12; 3; 12; 12; 6; 6; 12; 12; 6; 6 |
| Active Ingredient Units | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
| Substance Name | CAUSTICUM; CINCHONA OFFICINALIS BARK; COPPER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SULFUR; TOXICODENDRON PUBESCENS LEAF |
| Labeler Name | Walgreen Company |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large In |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED HOMEOPATHIC |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00363-7174-14 (00363717414)
| NDC Package Code | 0363-7174-14 |
|---|---|
| Billing NDC | 00363717414 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (0363-7174-14) / 50 TABLET in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2023-05-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |